Clarification - agreement for injectable regen bone filler

Summary by 6ix AI

Osteopore Ltd. has announced the clarification of its non-exclusive distribution agreement with dsm-firmenich for an injectable regenerative bone filler in Southeast Asia. The agreement is expected to contribute meaningfully to the company's revenue, contingent on successful commercialization and product registrations. The nominal fee associated with the agreement is not material to Osteopore's total assets. The company emphasizes that the annual minimum order quantities represent a small fraction of the total market opportunity in the region.

Written by 6ix AI from the company’s filing. How 6ix writes summaries